Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_assertion type Assertion NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_head.
- NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_assertion description "[Knockout of SIRT1 suppresses BCR-ABL transformation of mouse BM cells and the development of a CML-like myeloproliferative disease, and treatment of mice with the SIRT1 inhibitor tenovin-6 deters disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_provenance.
- NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_assertion evidence source_evidence_literature NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_provenance.
- NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_assertion SIO_000772 22207735 NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_provenance.
- NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_assertion wasDerivedFrom befree-20150227 NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_provenance.
- NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_assertion wasGeneratedBy ECO_0000203 NP219261.RAnCB29RrVO6zRR1cJ98FcUHcUce9PIEs2hpCHTp_w630130_provenance.